According to the results of the phase 3 CLEOPATRA trial, patients with non-center-involving diabetic macular edema who wore a light-emitting mask during sleep did not experience long-term therapeutic benefits.
The single-masked, parallel-group, randomized controlled trial included 308 patients with DME randomly assigned to wear either a light mask during sleep (Noctura 400 sleep mask, PolyPhotonix Medical) or a sham non-light mask for 24 months. Researchers examined the change in maximum retinal thickness on OCT from baseline to 24 months.
The study included 155 patients who wore the light mask
Uncategorized